Innovation

An Innovative System to Improve Cognition​

The COT/CBOT devices activate the olfactory system to strengthen the brain’s circuitry and counteract the effects of neural degeneration ​

An Innovative System to Improve Cognition​

The COT/CBOT devices activate the olfactory system to strengthen the brain’s circuitry and counteract the effects of neural degeneration ​

Methodologies and Applications

EvON Medics leads the development of breakthrough therapeutics and devices to address brain related conditions. This includes the improvement of cognitive function for individuals suffering from multiple stages of Alzheimer's Disease. Our neurological developments also address head trauma, opioid addiction recovery, depression, and chronic pain.

  • Help restore brain functioning after severe head injuries
  • Prevent relapse during recovery from OPIOID addition
  • Rapid enhancement of mood in treatment-refractory depression
  • Lasting treatments for chronic pain

Technologies

EvON Medics flagship Olfactory Treatment Delivery Systems (OTDS), as Disease Modifying Therapeutics (DMTs) in multiple unique formfactors, can contribute to the paradigm shift of treating chronic comorbid neurological and neurodegenerative health conditions.

Olfactory Treatment Delivery Systems (OTDS) aim to strengthen and regenerate the pathways of the olfactory system thereby slowing or stopping the progression of neurodegenerative disorders.

The OTDS uses the concept of chemosensory stimulation to stimulate the targeted regions of the brain with high fidelity thereby increasing the neuroplasticity of the targeted brain regions for the maintenance of neural function and the prevention of disease progression.

Olfactory Treatment Delivery Systems (OTDS) aim to strengthen and regenerate the pathways of the olfactory system thereby slowing or stopping the progression of neurodegenerative disorders.

The OTDS uses the concept of chemosensory stimulation to stimulate the targeted regions of the brain with high fidelity thereby increasing the neuroplasticity of the targeted brain regions for the maintenance of neural function and the prevention of disease progression.

Edge Over Competition

We focus on your mental well-being

Natural solutions

Our solutions use only natural substances rather than medication. Hence there are no side effects like weight gain and fatigue.

Improves cognition

Our Alzheimer’s Disease solution has been confirmed to improve cognition loss by an average of 5 points. No current therapeutic comes close to this.

Depression control

Our solutions improve depression symptoms. Unlike other medications from the competition, you can be sure of high spirits and maximum focus during daily activities.

Decision-making

You can be certain of improved decision-making when using our solutions for the treatment of Traumatic Brain Injuries. Unlike other therapeutics, ours actually depresses violent tendencies

Edge Over Competition

We focus on your mental well-being

Natural solutions

Our solutions use only natural substances rather than medication. Hence there are no side effects like weight gain and fatigue.

Depression control

Our solutions improve depression symptoms. Unlike other medications from the competition, you can be sure of high spirits and maximum focus during daily activities.

Improves cognition

Our Alzheimer’s Disease solution has been confirmed to improve cognition loss by an average of 5 points. No current therapeutic comes close to this.

Decision-making

You can be certain of improved decision-making when using our solutions for the treatment of Traumatic Brain Injuries. Unlike other therapeutics, ours actually depresses violent tendencies

Research and Development

Our Research and Development incorporates our medical expertise into software systems and devices. Our research is then validated through our specialized clinical trials processes.

Clinical Research and Validation

EvON Medics LLC has specialized expertise in conducting clinical research to identify unique approaches to diagnose and treat various neurodegenerative diseases. The Research & Development teams at EvON Medics excel in the design and development of novel Disease Modifying Therapeutics, especially for Alzheimer's Diseases, Alzheimer’s Related Dementia, Chronic Pain, Substance Use Disorder, Cognition Impairment, etc.

Critically evaluated and technically validated safety and efficacy of devices since 2018

Efficient interactions with the disease victims

Compassion to ease and cure patients’ suffering have inspired further development of multiple form factors of each technology.

Our Pipeline

Disease Modifying Therapeutics (DMTs) for neurological disorders in never before formfactors. Evon Medics pioneered the creation of OTDS technology based portable medical devices.

Co-Developed

Learn more about our growing portfolio companies

CO-DEVELOPMENT PARTNER
Fully Owned

EvON Medics is targeting a 2023 market launch

What Would You Like to Know About?

Please select one of our specialties to learn more

Want to Work With Us?

EvON Medics team will contact you within 3 business days after receiving an inquiry.